Epigenetic reprogramming with antisense oligonucleotides enhances the effectiveness of androgen receptor inhibition in castration-resistant prostate cancer

Published in

American Association for Cancer Research Inc.

Publication Year

2018

Link to paper

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054892755&doi=10.1158/000…

Type

Journal

Authors

Xiao L., Tien J.C., Vo J., Tan M., Parolia A., Zhang Y., Wang L., Qiao Y., Shukla S., Wang X., Zheng H., Su F., Jing X., Luo E., Delekta A., Juckette K.M., Xu A., Cao X., Alva A.S., Kim Y., MacLeod A.R., Chinnaiyan A.M.